Welcome to this new issue of HMPI. We continue to explore the boundaries of clinical medicine and business with new perspectives and research.
This issue begins with an examination of subscription models for application in healthcare, launching a discussion about how we finance services such as primary care and prevention in the United States. Subscription models could simultaneously blend novel digital services and with a new financial model for primary care services to fully support a digitally-enabled care model. Such a discussion is long overdue. At UCLA this year, no medical student went into pediatrics for residency training. It’s hard to imagine a clinical workforce comprised exclusively of physicians trained in dermatology and orthopedic surgery providing care for an aging population.
We then explore the concept of an AI-enabled electronic health record-could we build a modern digital infrastructure to support clinical care. It’s an exciting vision of where the technology could take us. Developing a marketing plan for such an approach is definitely an extra-credit assignment for our students given the entrancement of legacy systems in the market.
We are pleased once again to have highlights of the University of Miami’s annual healthcare conference. This meeting always brings together key leaders in the field for an exciting discussion.
Technology innovation is critical to the successful delivery of clinical care. But, how does this innovation occur and what are the barriers to innovation? We feature a comprehensive look at this issue from the University of Texas at Austin and Dell Medical School, featuring data gleaned from across the innovation landscape.
Novel research looks at the prevalence of high-deductible health plans to drive states to mandate price transparency for hospitals. This research paper examines this question and finds an effect before the national price transparency regulations went into effect.
In the case corner, we feature a new case on an exciting series from Harvard Business School on women business leaders in medicine. This case profiles CEO Amy Burroughs and her company, Cleave Therapeutics.
Overall, a very exciting issue. Enjoy!
Kevin Schulman, MD, MBA
BAHM President & HMPI Editor-in-Chief
Professor of Medicine, Stanford University